Dengue vaccine candidate: Takeda begins regulatory submissions in the EU and Dengue-endemic countries
by Press Release from Outbreak News Today on (#5FZRP)
Takeda Pharmaceutical Company announced recently that the European Medicines Agency (EMA) has accepted the Company's filing packages for its dengue vaccine candidate (TAK-003) which is being investigated for the prevention of dengue due to any dengue virus serotype in individuals ages four to 60. In addition, they intend on submitting regulatory filings this year in [...]
The post Dengue vaccine candidate: Takeda begins regulatory submissions in the EU and Dengue-endemic countries appeared first on Outbreak News Today.